{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:08:52Z","timestamp":1790111332626,"version":"4.0.1"},"reference-count":56,"publisher":"The Journal of Rheumatology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2026,2,5]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Gut microbiota dysbiosis has been implicated in the pathogenesis of autoimmune and immune-mediated arthritis. Biologics may influence gut microbiota composition; however, it is uncertain whether biologics act directly on microbial communities or indirectly through disease modulation and restoration of immune homeostasis. This systematic review explores how biologic therapies modulate gut microbiota in autoimmune arthritis and their potential as biomarkers for treatment response and disease activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Scopus, Cochrane Library, and Web of Science for studies assessing gut microbiota changes induced by any biologic therapy in immune-mediated or autoimmune arthritis. The outcomes included changes in microbiota and the potential for microbiota as predictive biomarkers for treatment response and disease activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 12 studies were included. Biologic agents, predominantly tumor necrosis factor inhibitors and interleukin 17 inhibitors, significantly altered gut microbiota composition and diversity, with most studies showing increased \u03b1-diversity and normalization of \u03b2-diversity post therapy; however, these effects were not uniformly consistent. Treatment restored beneficial short-chain fatty acid\u2013producing taxa, including\n                      <jats:italic>Faecalibacterium prausnitzii<\/jats:italic>\n                      ,\n                      <jats:italic>Megamonas<\/jats:italic>\n                      ,\n                      <jats:italic>Lachnoclostridium<\/jats:italic>\n                      , and\n                      <jats:italic>Blautia<\/jats:italic>\n                      , while reducing inflammatory genera such as\n                      <jats:italic>Escherichia<\/jats:italic>\n                      -\n                      <jats:italic>Shigella<\/jats:italic>\n                      and\n                      <jats:italic>Klebsiella<\/jats:italic>\n                      . Certain taxa, notably\n                      <jats:italic>Lachnospiraceae<\/jats:italic>\n                      and\n                      <jats:italic>Megamonas<\/jats:italic>\n                      , correlated with clinical improvement and reduced disease activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Biologic therapy modulates gut microbiota composition in autoimmune and immune-mediated arthritis, promoting a shift toward eubiosis. Specific microbial taxa, including\n                      <jats:italic>Lachnospiraceae<\/jats:italic>\n                      ,\n                      <jats:italic>Blautia<\/jats:italic>\n                      , and\n                      <jats:italic>F. prausnitzii<\/jats:italic>\n                      , show potential as noninvasive biomarkers for treatment response and disease activity. These findings guide further longitudinal and interventional studies to validate microbial signatures and their clinical applicability.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2025-0915","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T13:20:14Z","timestamp":1771161614000},"page":"739-751","source":"Crossref","is-referenced-by-count":1,"title":["Gut Microbiota as a Biomarker and Target in Biologic Therapy for Autoimmune and Immune-Mediated Arthritis: A Systematic Review"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0042-4992","authenticated-orcid":false,"given":"Madhumitha","family":"Rondla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0904-9153","authenticated-orcid":false,"given":"Mohamed Sayed","family":"Zaazouee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4393-4474","authenticated-orcid":false,"given":"Arya Akhila","family":"Perumangote Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1350-3465","authenticated-orcid":false,"given":"Karthik","family":"Mathialagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6100-7626","authenticated-orcid":false,"given":"Rewanth","family":"Katamreddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"2026070105202369000_53.7.739.1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4517"},{"key":"2026070105202369000_53.7.739.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5145"},{"key":"2026070105202369000_53.7.739.3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00282"},{"key":"2026070105202369000_53.7.739.4","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat Microbiol"},{"key":"2026070105202369000_53.7.739.5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrrheum.2014.207","article-title":"Spondyloarthropathies: gut dysbiosis in ankylosing spondylitis","volume":"11","author":"Barranco","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2026070105202369000_53.7.739.6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.906258"},{"key":"2026070105202369000_53.7.739.7","doi-asserted-by":"publisher","DOI":"10.1096\/U&#x0308;.202201728R"},{"key":"2026070105202369000_53.7.739.8","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020574"},{"key":"2026070105202369000_53.7.739.9","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3390\/microorganisms11092170","article-title":"Decoding the microbiome\u2019s influence on rheumatoid arthritis","volume":"11","author":"Coradduzza","year":"2023","journal-title":"Microorganisms"},{"key":"2026070105202369000_53.7.739.10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1007165"},{"key":"2026070105202369000_53.7.739.11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/microorganisms10030578","article-title":"Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options","volume":"10","author":"Hrncir","year":"2022","journal-title":"Microorganisms"},{"key":"2026070105202369000_53.7.739.12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41584-020-0454-9","article-title":"Revisiting the gut\u2013joint axis: links between gut inflammation and spondyloarthritis","volume":"16","author":"Gracey","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026070105202369000_53.7.739.13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.40827","article-title":"Microbiome analytics of the gut microbiota in patients with juvenile idiopathic arthritis: a longitudinal observational cohort study","volume":"71","author":"Van Dijkhuizen","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026070105202369000_53.7.739.14","first-page":"459","article-title":"Microbiome and gut dysbiosis","volume":"109","author":"Beliz\u00e1rio","year":"2018","journal-title":"Exp Suppl"},{"key":"2026070105202369000_53.7.739.15","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9259646"},{"key":"2026070105202369000_53.7.739.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31491-5"},{"key":"2026070105202369000_53.7.739.17","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/biom10111479","article-title":"DMARDs\u2013gut microbiota feedback: implications in the response to therapy","volume":"10","author":"Zaragoza-Garc\u00eda","year":"2020","journal-title":"Biomolecules"},{"key":"2026070105202369000_53.7.739.18","doi-asserted-by":"crossref","first-page":"1189036","DOI":"10.3389\/fimmu.2023.1189036","article-title":"Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis","volume":"14","author":"Fan","year":"2023","journal-title":"Front Immunol"},{"key":"2026070105202369000_53.7.739.19","first-page":"e71111","article-title":"The role of gut microbiota in the efficacy and side effect profile of biologic therapies for autoimmune diseases","volume":"16","author":"Qusty","year":"2024","journal-title":"Cureus"},{"key":"2026070105202369000_53.7.739.20","doi-asserted-by":"crossref","first-page":"127660","DOI":"10.1016\/j.micres.2024.127660","article-title":"Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: a comprehensive systematic review","volume":"282","author":"Wang","year":"2024","journal-title":"Microbiol Res"},{"key":"2026070105202369000_53.7.739.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"2026070105202369000_53.7.739.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"2026070105202369000_53.7.739.23","doi-asserted-by":"crossref","first-page":"700570","DOI":"10.3389\/fimmu.2021.700570","article-title":"Adalimumab therapy restores the gut microbiota in patients with ankylosing spondylitis","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"2026070105202369000_53.7.739.24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/FPC.0000000000000468","article-title":"Association of Anti-TNF-\u03b1 treatment with gut microbiota of patients with ankylosing spondylitis","volume":"32","author":"Dai","year":"2022","journal-title":"Pharmacogenet Genomics"},{"key":"2026070105202369000_53.7.739.25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19102938"},{"key":"2026070105202369000_53.7.739.26","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001755"},{"key":"2026070105202369000_53.7.739.27","doi-asserted-by":"crossref","first-page":"105868","DOI":"10.1016\/j.jbspin.2025.105868","article-title":"Evolution of gut microbiota in psoriatic arthritis treated with IL-17 inhibitor revealed by metagenomics","volume":"92","author":"Liu","year":"2025","journal-title":"Joint Bone Spine"},{"key":"2026070105202369000_53.7.739.28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.41169","article-title":"Interleukin-17 inhibition in spondyloarthritis is associated with subclinical gut microbiome perturbations and a distinctive interleukin-25-driven intestinal inflammation","volume":"72","author":"Manasson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2026070105202369000_53.7.739.29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12969-021-00542-0","article-title":"Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept","volume":"19","author":"\u00d6man","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026070105202369000_53.7.739.30","doi-asserted-by":"crossref","first-page":"e15218","DOI":"10.1111\/1756-185X.15218","article-title":"Combined analysis of metabolomics and 16S rRNA sequencing for ankylosing spondylitis patients before and after secukinumab therapy","volume":"27","author":"Sun","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"2026070105202369000_53.7.739.31","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002794"},{"key":"2026070105202369000_53.7.739.32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215763"},{"key":"2026070105202369000_53.7.739.33","first-page":"99","article-title":"Dynamic variations in gut microbiota in ankylosing spondylitis patients treated with anti-TNF-\u03b1 for six months","volume":"50","author":"Zhang","year":"2020","journal-title":"Ann Clin Lab Sci"},{"key":"2026070105202369000_53.7.739.34","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1038\/s41598-018-23571-4","article-title":"Microbiota composition may predict anti-Tnf alpha response in spondyloarthritis patients: an exploratory study","volume":"8","author":"Bazin","year":"2018","journal-title":"Sci Rep"},{"key":"2026070105202369000_53.7.739.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77864-y"},{"key":"2026070105202369000_53.7.739.36","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2676"},{"key":"2026070105202369000_53.7.739.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0176-y"},{"key":"2026070105202369000_53.7.739.38","doi-asserted-by":"crossref","first-page":"100316","DOI":"10.1016\/j.jtauto.2025.100316","article-title":"Short-chain fatty acids from gut microbiota restore Th17\/Treg balance in rheumatoid arthritis: mechanisms and therapeutic potential","volume":"11","author":"Pang","year":"2025","journal-title":"J Transl Autoimmun"},{"key":"2026070105202369000_53.7.739.39","doi-asserted-by":"crossref","first-page":"1365554","DOI":"10.3389\/fimmu.2024.1365554","article-title":"Emerging role of gut microbiota in autoimmune diseases","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"2026070105202369000_53.7.739.40","doi-asserted-by":"crossref","first-page":"746998","DOI":"10.3389\/fimmu.2021.746998","article-title":"Causal relationship between gut microbiota and autoimmune diseases: a two-sample Mendelian randomization study","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"2026070105202369000_53.7.739.41","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kead364","article-title":"Autoimmune diseases exhibit shared alterations in the gut microbiota","volume":"63","author":"Wang","year":"2024","journal-title":"Rheumatology"},{"key":"2026070105202369000_53.7.739.42","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.230014"},{"key":"2026070105202369000_53.7.739.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59016-0"},{"key":"2026070105202369000_53.7.739.44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00296-024-05614-4","article-title":"The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study","volume":"44","author":"Chmieli\u0144ska","year":"2024","journal-title":"Rheumatol Int"},{"key":"2026070105202369000_53.7.739.45","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa253"},{"key":"2026070105202369000_53.7.739.46","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/ibd\/izab273","article-title":"RAID prediction: pilot study of fecal microbial signature with capacity to predict response to anti-TNF treatment","volume":"27","author":"Busquets","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2026070105202369000_53.7.739.47","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.11.304"},{"key":"2026070105202369000_53.7.739.48","doi-asserted-by":"crossref","first-page":"1227309","DOI":"10.3389\/fmicb.2023.1227309","article-title":"Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related functional changes","volume":"14","author":"Du","year":"2023","journal-title":"Front Microbiol"},{"key":"2026070105202369000_53.7.739.49","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s40261-019-00849-7","article-title":"Gut microbiome in psoriasis is perturbed differently during secukinumab and ustekinumab therapy and associated with response to treatment","volume":"39","author":"Yeh","year":"2019","journal-title":"Clin Drug Investig"},{"key":"2026070105202369000_53.7.739.50","doi-asserted-by":"crossref","first-page":"906419","DOI":"10.3389\/fphar.2022.906419","article-title":"Alterations and potential applications of gut microbiota in biological therapy for inflammatory bowel diseases","volume":"13","author":"Pu","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026070105202369000_53.7.739.51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12866-023-03107-1","article-title":"Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Microbiol"},{"key":"2026070105202369000_53.7.739.52","doi-asserted-by":"crossref","first-page":"802","DOI":"10.21037\/atm-22-3236","article-title":"Efficacy and safety of fecal microbiota transplantation for the induction of remission in active ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Wei","year":"2022","journal-title":"Ann Transl Med"},{"key":"2026070105202369000_53.7.739.53","doi-asserted-by":"crossref","first-page":"112501","DOI":"10.1016\/j.intimp.2024.112501","article-title":"Therapeutic potential of probiotics in gut microbial homeostasis and rheumatoid arthritis","volume":"137","author":"Balasundaram","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"2026070105202369000_53.7.739.54","first-page":"57","article-title":"Probiotics\u2014a probable therapeutic agent for spondyloarthropathy","volume":"12","author":"Singh","year":"2017","journal-title":"Int J Probiotics Prebiotics"},{"key":"2026070105202369000_53.7.739.55","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ccr3.3677","article-title":"Fecal microbiota transplantation for rheumatoid arthritis: a case report","volume":"9","author":"Zeng","year":"2021","journal-title":"Clin Case Rep"},{"key":"2026070105202369000_53.7.739.56","doi-asserted-by":"crossref","first-page":"1093233","DOI":"10.3389\/fimmu.2023.1093233","article-title":"Case report: fecal microbiota transplantation in refractory ankylosing spondylitis","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:59:24Z","timestamp":1782910764000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.3899\/jrheum.2025-0915"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0915","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]}}}